Back to calendar
Telomir Pharmaceuticals, Inc. (TELO) Earnings
TELO reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.07
Company overview
Market Cap$82.5M
PriceUSD 1.20
EPS (TTM)-0.29
52-week high2.09
52-week low0.89
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees2